The regulatory file for CLA oil
A CLA oil regulatory file ties one specification to one destination. It carries the CLA figure and its basis, the isomer profile, the free fatty acid and peroxide values, the contaminant results, the intake arithmetic and the label name. The buyer's regulatory team confirms that route — the finished product, the dose and the local rules decide it — and this page sets out the papers and checks the folder should hold.
The regulatory file ties one lot of CLA oil to one destination: the CLA figure and its basis, the isomer profile, the oxidation values, the label name and the intake arithmetic all have to agree.
What the file has to answer
Four questions run through the file. Which material is it — the CLA range, the esterified form and the isomer split? Which lot does the certificate cover, and what did it measure? Does the intended use and daily intake fit the destination's route and limits? And how are a new feedstock, a new refinery step or a new pack handled when they arrive?
Each document answers only part of that. A certificate speaks for one lot, a data sheet describes the material in general, and neither decides the market route. The intake calculation, the label review and the novel-food or dietary-ingredient check are separate tasks, each dated and versioned in the folder.
European Union and the United Kingdom
The EU review rests on three instruments: Regulation (EC) No 178/2002 for general food law, Regulation (EU) No 1169/2011 for consumer information, and Regulation (EU) 2023/915 for contaminant limits in force at the time of writing. A CLA-rich oil also raises the novel-food question under Regulation (EU) 2015/2283, and the answer depends on the use and the process. CLA-rich oils have been sold in food supplements in the Union since the 1990s, which is a starting point rather than an answer: an entry can be tied to a defined specification and to a maximum intake, and a food use outside supplements is a separate question. Check the current Union list and the novel-food catalogue against the material you buy, as of this review.
Great Britain applies the retained framework with its own register and labelling, while Northern Ireland follows the EU rules, so the two do not share one file. The delivery address decides which set applies, and the buyer records that call with the order.
Refined CLA oil brings the process contaminants into scope. 3-MCPD and its fatty acid esters, and glycidyl fatty acid esters, form during deodorisation, and the refinery should state its deodorisation route and supply results where the destination sets a level. A cold-pressed or unrefined route has a different profile but still needs the pesticide, PAH and mineral-oil statements the market requires.
United States
In the United States, CLA oil goes to market as a dietary ingredient, so the file depends on the basis the supplier asserts. The supplier states that basis and supplies the document behind it; the buyer checks that it reaches the finished product. The Federal Food, Drug, and Cosmetic Act, the labelling rules in 21 CFR 101 and the supplement cGMPs in 21 CFR 111 are the working references.
The Supplement Facts panel declares conjugated linoleic acid by name with the amount per serving, and the ingredient statement lists the oil and any antioxidant. A structure or function statement needs the DSHEA disclaimer and must not be a disease claim. If the oil is used as a food ingredient rather than in a supplement, a different basis applies and it is checked separately; a supplement file does not carry across.
Limits and the intake calculation
The table is the starting point for the finished-product review. The current destination text and the daily intake decide the final limit, not the catalog specification alone.
| Parameter | Release target | What the file must show |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Measured value, method and intake arithmetic |
| Arsenic (As) | ≤2 mg/kg | Lot value against the agreed target |
| Cadmium (Cd) | ≤1 mg/kg | Measured value; category exceptions noted |
| Mercury (Hg) | ≤0.1 mg/kg | Measured value with the method |
| Free fatty acid and peroxide value | ≤0.50% and ≤5.0 meq O₂/kg | Lot values plus the storage record |
| 3-MCPD and glycidyl esters | Destination limit | Refining record and results where a limit applies |
| Polycyclic aromatic hydrocarbons | Destination limit | Results against the current list |
| Mineral oil hydrocarbons | Customer specification | Screen result and limit of quantification |
Every result has to be converted to the daily intake of the finished product and compared with the destination rule. A heavy-metal panel catches neither the process-contaminant nor the oxidation question, and an oxidation result does not cover metals. The file needs both, and the calculation needs the inclusion rate, not the oil result alone.
Label and claims
The label names the material and the amount. In the EU the ingredient appears in the ingredients list, the nutrition declaration carries fat and saturates, and the CLA amount is stated per portion from the oil weight and the CLA figure. In the US the Supplement Facts panel names conjugated linoleic acid per serving. In both markets the CLA figure needs its basis: mass per serving, from the oil, on the fatty-acid basis the certificate uses.
A claim is a separate review. In the EU, nutrition and health claims must be permitted under Regulation (EC) No 1924/2006 and, for health claims, must appear on the Register of authorised claims; the reviewer checks the current entry before the wording is used. A composition figure such as the CLA content is not by itself a claim. In the US a structure or function statement is the brand's responsibility, needs substantiation and the DSHEA disclaimer, and must not be a disease claim. No disease-related claim is made on this page.
Documents in the file
- Version-controlled specification with the CLA range, the esterified form and the isomer split.
- Lot certificate with the methods, the results and the basis of the CLA figure.
- Technical data sheet and safety data sheet.
- Allergen, GMO and country-of-origin statements.
- Isomerisation and refining record, including the deodorisation step.
- Heavy-metal, process-contaminant, pesticide, PAH and mineral-oil statements as required.
- Pack declaration, lot-code traceability and retained-sample record.
Checklist before the first order
- The CLA range, the esterified form, the isomer split and the specification version are fixed in writing.
- COA, TDS, SDS, allergen, GMO and origin records are present and dated.
- Each contaminant result has been recalculated at the finished-product inclusion rate.
- The label name, the CLA basis and the claim wording have been reviewed for the destination.
- The novel-food or dietary-ingredient route is recorded with the date it was checked.
- Quotation, specification and certificate cite the same version.
The catalog limits are on the CLA oil product page, the release lines are on the COA page, the identity tests are on the identity page, the powder is specified on the CLA powder page, market frameworks are summarised in the EU regulatory note, the analytical methods are indexed under methods, and release is described on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation